VZ
37
3
CI
40
2
F
42
2
STT
64
4
APH
65
4
NUE
51
3
UA
48
9
BAX
41
3
IPG
50
2
STI
28
9
UNH
55
5
CMA
53
3
MHK
46
3
NWSA
78
5
AIV
51
4
HP
41
5
AA
47
4
BA
48
-5
BF.B
31
2
WU
36
2
VZ
37
3
CI
40
2
F
42
2
STT
64
4
APH
65
4
NUE
51
3
UA
48
9
BAX
41
3
IPG
50
2
STI
28
9
UNH
55
5
CMA
53
3
MHK
46
3
NWSA
78
5
AIV
51
4
HP
41
5
AA
47
4
BA
48
-5
BF.B
31
2
WU
36
2
Financhill
Back

RF Industries 10K Form

Sell
22

RFIL
RF Industries

Last Price:
4.15
Seasonality Move:
7.66%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RFIL News And Ratings

See the #1 stock for the next 7 days that we like better than RFIL

RFIL Financial Statistics

Sales & Book Value

Annual Sales: $72.17M
Cash Flow: $2.12M
Price / Cash Flow: 10.08
Annual Sales: $3.25
Price / Book: 1.27

Profitability

EPS (TTM): -0.69000
Net Income (TTM): $-7.21M
Gross Margin: $19.54M
Return on Equity: -19.23%
Return on Assets: -9.39%

RF Industries Earnings Forecast

Key RF Industries Financial Ratios

  • The Gross Profit Margin over the past 28 years for RFIL is 27.07%.
  • The Selling, General & Administrative Expenses for RFIL have been equal to 27.97% of Gross Profit Margin.
  • The Research & Development expenses have been 4.37% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of RFIL is -4.27% of Total Revenues.
  • Per Share Earnings over the last 28 years have been positive in 14 years.

RF Industries Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Electronic Equipment, Instruments & Components
Sector: Information Technology
Current Symbol: RFIL
CUSIP: 749552
Website: rfindustries.com

Debt

Debt-to-Equity Ratio: 0.26
Current Ratio: 1.6
Quick Ratio: 0.68

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RFIL Technical Analysis vs Fundamental Analysis

Sell
22
RF Industries (RFIL) is a Sell

Is RF Industries a Buy or a Sell?

  • RF Industries stock is rated a Sell
    The current RF Industries [RFIL] share price is $4.14. The Score for RFIL is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.